Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection

NCT ID: NCT02241980

Last Updated: 2022-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this project is to evaluate patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).

The primary objective of this project is to determine the percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs.Secondary objectives are to determine:

1. The percentage of patients who have switched or considered switching their Medicare Part D PDP at any point during their enrollment
2. The most commonly used resources used by beneficiaries to aid in selection of a Medicare Part D PDP
3. The percentage of patients who reach the Medicare Part D donut hole as a result of their current plan
4. Physician perception of appropriate selection of Medicare Part D PDP among their patient panel
5. Physician perception of administrative time spent resolving medication issues related to Medicare Part D PDPs

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medicare Part D

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medicare Part D patients

Survey

Patient survey

Intervention Type OTHER

Physician Providers

Survey

Physician survey

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient survey

Intervention Type OTHER

Physician survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
* Medicare A/B is listed as primary insurance
* Patients 65 years old or older


* Physicians of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center

Exclusion Criteria

* Patients less than the age of 65 years old
* Patients with Medicare Advantage plan

Physician Population
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ohio State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stuart Beatty

Associate Professor - Clinical

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stuart Beatty, PharmD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Martha Morehouse Internal Medicine Clinic at Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014H0191

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Message Testing for CKD
NCT05462158 COMPLETED NA